working

Sign in

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account


Sign In
Not a commercial user? Register here for our wider research bundle

More Content

More Content

PANMURE LIBERUM: Scancell Holdings: Increasing SCOPE: More data + Phase 3

Companies: Scancell Holdings Plc

OSE Immunotherapeutics:Strategic plan presented for 2026–2028

Companies: Ose Immunotherapeutics (OSE:EPA)OSE Immunotherapeutics SA (OSE:PAR)

MTVA: New Date for Vanoglipel (DA-1241) Presented at AASLD

Companies: MetaVia Inc.

FDA Trial Halted After Interim Results; Core Business On Track To Grow By Double Digits In 2026; Raise EPS Estimates To Reflect Lower R&D Spending; Balance Sheet Solid; Maintain $13 Target

Companies: Kamada Ltd

Mendus:ASH 2025 update supports renewed strategy

Companies: IMMUNICUM (IMMU:STO)Mendus AB (IMMU:OME)

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top